teaser
↓Article continues below this sponsored advert↓
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE
↑Advertisement↑
Following a comprehensive analysis of pre- and postmarketing data by the UK’s MHRA and Commission on Human Medicines, the risk-benefit profile for rosuvastatin (Crestor
